NCT05442515
- Conditions
- Acute Lymphoblastic Leukemia, Acute Lymphocytic Leukemia, Acute Lymphoid Leukemia, +34 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
Clinical trial condition
Leukemia, B-Cell
Explore clinical trials studying Leukemia, B-Cell. Study availability and eligibility vary by location and protocol.
121 public trials
28 recruiting studies
Leukemia, B-Cell trial results
NCT04728893
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Chronic Lymphocytic Leukaemia, +24 more
- Locations
-
- Highlands Oncology Group ( Site 2728) Springdale, Arkansas, United States
- University of California San Diego Moores Cancer Center ( Site 2717) La Jolla, California, United States
- Lundquist Institute for Biomedical Innovation at Harbor-UCLA-Hematology and Medical Oncology ( Site 2724) Torrance, California, United States
- Colorado Blood Cancer Institute ( Site 2726) Denver, Colorado, United States
NCT06542250
- Conditions
- B-cell Malignancies, Chronic Disease, Disease Attributes, +19 more
- Locations
-
- Research Site La Jolla, California, United States
- Research Site Boston, Massachusetts, United States
- Research Site Rochester, Minnesota, United States
- Research Site Hackensack, New Jersey, United States
NCT05254743
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +20 more
- Locations
-
- Pacific Cancer Medical Center, Inc Anaheim, California, United States
- TOI Clinical Research Cerritos, California, United States
- Stanford School of Medicine-Cancer Clinical Trials Office Palo Alto, California, United States
- California Cancer Associates for Research and Excellence San Marcos, California, United States
- Conditions
- Blood Protein Disorders, CLL (Chronic Lymphocytic Leukemia), Cardiovascular Diseases, +29 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
NCT07509151
- Conditions
- Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated IGHV, Hematologic Diseases, Hemic and Lymphatic Diseases, +10 more
- Locations
-
- Research Site Adelaide, Australia
- Research Site Fitzroy, Australia
- Research Site Heidelberg, Australia
- Research Site Nedlands, Australia
Recruiting
A Study of MRD-Guided Zanubrutinib Plus Sonrotoclax in Treatment-Naïve, High-Risk CLL/SLL Patients
NCT07671378
- Conditions
- CLL (Chronic Lymphocytic Leukemia), Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
- Locations
-
- Jiangsu Province Hospital Nanjing, Jiangsu, China
NCT03050190
- Conditions
- B-cell Malignancies, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
- Locations
-
- Shenzhen Geno-immune Medical Institute Shenzhen, Guangdong, China
NCT03125577
- Conditions
- B-cell Malignancies, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
- Locations
-
- Shenzhen Geno-immune Medical Institute Shenzhen, Guangdong, China
Recruiting
CAR-T Immunotherapy Targeting CD19- ALL
NCT04016129
- Conditions
- B-cell Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
- Locations
-
- Shenzhen Geno-immune Medical Institute Shenzhen, Guangdong, China